You can be assured that Sensera did not report without querying the ASX.
I am in a state of shock that the company added on "It should be noted that NanoDX is still pursuing FDA approval". Shareholders just wanted to hear that the company was out of the picture !!
SE1 Price at posting:
4.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.